Related Experiment Video
Updated: Jun 4, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
[TREATMENT UPDATES IN OCULAR ONCOLOGY]
1Ophthalmology Department, Shaare Tzedek Medical Center.
Introduction:
Malignant tumors of the eye are uncommon, yet of great importance due to their effect on the patient's life and vision. The most common primary intraocular tumors are retinoblastoma in children and uveal melanoma in adults. The most common periocular tumor is basal cell carcinoma in eyelids. Management of these tumors can be challenging. On one hand, it can be difficult to control intraocular tumors like retinoblastoma or uveal melanoma from spreading out of the eye which will decrease the chances of survival of these patients. On the other hand, in eyelid tumors that have spread into the ocular tissue, this can make it surgically non-removable. In the past decades, many new treatments, local and systemic, have emerged with the main aim of saving the patient's life, as well as saving the globe of the eye and when possible, the vision. This has improved the overall survival of these patients. In this article, we reviewed the latest advances in the treatment of these tumors in the past decade. In addition, we reviewed the advances in the management and treatment of conjunctival melanoma, a very rare but lethal malignant tumor of the eye.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Tumor Immunotherapy
Glaucoma: Overview

